Clinical trial · Interventional
Overlooked Population at Risk for AIN.
The Overlooked Population at Risk for AIN: Women With High-grade Lower Genital Tract Dysplasia or Cervical Cancer.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the possibility and compliance of performing anal Pap smear and Human Papilloma Virus (HPV) DNA testing on women with high grade lower genital tract dysplasia or cervical cancer and determining the prevalence of anal dysplasia in this population using a high-resolution anoscopy (HRA). In addition, it is being done to potentially develop screening, diagnostic and treatment protocol for anal dysplasia in women with high-grade lower genital tract dysplasia or cervical cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| High Grade Cervical Dysplasia | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Screening Anal Pap Smear - No High Resolution Anoscopy | Procedure | — | UNRESOLVED |
| Screening Anal Pap Smear - With High Resolution Anoscopy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Anal Screening Pap Smear - Negative
- description
- Anal Pap Smear with no High Resolution Anoscopy
- interventionNames
- Procedure: Screening Anal Pap Smear - No High Resolution Anoscopy
- type
- OTHER
- label
- Anal Pap Smear - Positive Result - High Resolution Anoscopy
- description
- Patient who have a positive anal pap smear will go on to have a high resolution anoscopy.
- interventionNames
- Procedure: Screening Anal Pap Smear - With High Resolution Anoscopy
Primary outcomes (1)
- measure
- Prevalence
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Women ≥ 40 years old * Previous or current high grade cervical dysplasia or cervical cancer Exclusion Criteria: * Women ≥ 40 years old because the median time between the diagnosis of anal cancer and previous cervical cancer is approximately 20 years. * chemotherapy or radiation therapy within the last 6 months
References
Publications (0)
Data not yet available